News / Taiwan / economic_daily
Sunstar Medical August Revenue Surges Over 40% YoY to NT$40.82 Million
Health Technology · Medical Specialties · economic_daily · 2026-09-09
7726
Sunstar Medical reports strong August revenue growth driven by robust sales in Europe, North America, and emerging markets, marking a 43% year-over-year increase.
What Happened
Financial Performance: Sunstar Medical reported August 2026 consolidated revenue of NT$40.82 million, representing a 13.63% monthly increase and a 43.09% year-over-year surge. Cumulative revenue for the first eight months reached NT$270 million, up 37.11% compared to the same period last year.
Product Strategy: The company focuses on pressure care and wound management, with therapeutic support surface systems serving as its primary revenue driver. It is also expanding its portfolio by promoting negative pressure wound therapy systems to capture broader market opportunities.
Global Expansion: Sunstar is actively pursuing international regulatory certifications, with plans to register products in Singapore, Colombia, India, Thailand, and Egypt by the end of the year. These efforts are aimed at broadening the company's addressable market and enhancing its global footprint.
Future Outlook: With a strong presence in Europe, North America, the UK, and Australia, the company is now targeting further growth in Asian and emerging markets. Management remains focused on core product development and adapting to regional demand to sustain long-term business momentum.